Literature DB >> 31090137

Oral submucous fibrosis: A global challenge. Rising incidence, risk factors, management, and research priorities.

Jay Gopal Ray1, Raghunath Chatterjee2, Keya Chaudhuri3.   

Abstract

Oral submucous fibrosis is a potentially malignant disorder of the oral cavity, with a high rate of malignant transformation. It is very common among habitual areca nut chewers. The pathogenesis of oral submucous fibrosis is not well established, but it is believed to be a disease of multifactorial origin, including areca nut chewing, ingestion of chilies, genetic factors, immunologic processes and nutritional deficiencies. Genetically susceptible individuals when exposed to areca nut chewing develop this disease over a variable period of time. Oral submucous fibrosis is considered to be a disease of collagen metabolism. Several genetic factors are reported but there is no consensus about the exact mechanism of disease initiation. Variations in histopathological presentation are noted among oral submucous fibrosis patients with habitual areca nut chewing in different forms and other additive agents, eg betel quid, pan masala and gutkha, together with a variety of tobacco habits. The role of epigenetic modifications, such as miRNA regulation, and DNA methylation is also being reported as part of the pathogenesis of oral submucous fibrosis. A combined approach, including analysis of genetic and epigenetic regulations with different habits, might be helpful to better understand the contributory factors and pathogenesis of this serious disorder.
© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Mesh:

Year:  2019        PMID: 31090137     DOI: 10.1111/prd.12277

Source DB:  PubMed          Journal:  Periodontol 2000        ISSN: 0906-6713            Impact factor:   7.589


  13 in total

1.  [Efficacy of curcumin in the treatment of oral submucous fibrosis: a Meta-analysis].

Authors:  Jin-Cai Guo; Hui Xie; Hao Wu; Tie-Jun Tong
Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi       Date:  2021-04-01

2.  A novel approach to develop an animal model for oral submucous fibrosis.

Authors:  Madhura Shekatkar; Supriya Kheur; Avinash Sanap; Vaishali Undale; Avinash Kharat; Vrushali Bhalchim; Arati Dubewar; Ramesh Bhonde
Journal:  Med Oncol       Date:  2022-08-16       Impact factor: 3.738

3.  The study of placentrex and hydrocortisone as an adjunct treatment in oral submucous fibrosis.

Authors:  Parag Kisave; Vijay Shekhar; Prasoon S Babu; Syed W U Hussaini; Rishabh Bhanot; Abhinav Kumar; Rahul V C Tiwari
Journal:  J Family Med Prim Care       Date:  2020-05-31

Review 4.  Loss of oral mucosal stem cell markers in oral submucous fibrosis and their reactivation in malignant transformation.

Authors:  Mohit Sharma; Felipe Paiva Fonseca; Keith D Hunter; Raghu Radhakrishnan
Journal:  Int J Oral Sci       Date:  2020-08-21       Impact factor: 6.344

5.  Betel quid chewing and oral potential malignant disorders and the impact of smoking and drinking: A meta-analysis.

Authors:  Hui-Jun Lin; Xiao-Lei Wang; Meng-Yuan Tian; Xing-Li Li; Hong-Zhuan Tan
Journal:  World J Clin Cases       Date:  2022-04-06       Impact factor: 1.534

6.  Oral Submucous Fibrosis: Correlation of Clinical Grading to Various Habit Factors.

Authors:  Vikash K Jha; Srinivas Kandula; Sangamesh Ningappa Chinnannavar; Purnendu Rout; Silpiranjan Mishra; Atul A Bajoria
Journal:  J Int Soc Prev Community Dent       Date:  2019-06-27

7.  Triphala extract negates arecoline-induced senescence in oral mucosal epithelial cells in vitro.

Authors:  Shankargouda Patil; Sachin C Sarode; Heba Ashi; Hosam Ali Baeshen; A Thirumal Raj; Kamran H Awan; Shailesh Gondivkar; Amol Ramchandra Gadbail; Gargi S Sarode
Journal:  Saudi J Biol Sci       Date:  2021-01-21       Impact factor: 4.219

Review 8.  Research Achievements of Oral Submucous Fibrosis: Progress and Prospect.

Authors:  Hui Xu; Feng-Yuan Lyu; Jiang-Yuan Song; Yu-Ming Xu; Er-Hui Jiang; Zheng-Jun Shang; Li-Li Chen; Zhi Xu
Journal:  Biomed Res Int       Date:  2021-03-18       Impact factor: 3.411

Review 9.  Research progress on drugs targeting the TGF-β signaling pathway in fibrotic diseases.

Authors:  Ning Shi; Zhihong Wang; Hecheng Zhu; Weidong Liu; Ming Zhao; Xingjun Jiang; Jin Zhao; Caiping Ren; Yan Zhang; Longlong Luo
Journal:  Immunol Res       Date:  2022-02-11       Impact factor: 4.505

10.  Identification of a BRAF/PA28γ/MEK1 signaling axis and its role in epithelial-mesenchymal transition in oral submucous fibrosis.

Authors:  Changqing Xie; Zaiye Li; Yufei Hua; Silu Sun; Liang Zhong; Qian Chen; Hui Feng; Ning Ji; Taiwen Li; Xikun Zhou; Xin Zeng; Zhangui Tang; Chongkui Sun; Jing Li; Qianming Chen
Journal:  Cell Death Dis       Date:  2022-08-12       Impact factor: 9.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.